TJBH
Tengjun Biotechnology Corp
Price:  
2.00 
USD
Volume:  
150.00
China | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TJBH WACC - Weighted Average Cost of Capital

The WACC of Tengjun Biotechnology Corp (TJBH) is 6.4%.

The Cost of Equity of Tengjun Biotechnology Corp (TJBH) is 6.60%.
The Cost of Debt of Tengjun Biotechnology Corp (TJBH) is 4.25%.

Range Selected
Cost of equity 5.40% - 7.80% 6.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 4.50% 4.25%
WACC 5.2% - 7.5% 6.4%
WACC

TJBH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.33 0.53
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.07 0.07
Cost of debt 4.00% 4.50%
After-tax WACC 5.2% 7.5%
Selected WACC 6.4%

TJBH's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for TJBH:

cost_of_equity (6.60%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.33) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.